Journal:JBSD:4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (11:14, 31 August 2012) (edit) (undo)
 
(16 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='' size='450' side='right' scene='Journal:JBSD:4/Cv/1' caption=''>
+
<StructureSection load='JBSD4.pdb' size='450' side='right' scene='Journal:JBSD:4/Cv/2' caption='' >
 +
=== Dominant-negative Effects in Prion Diseases: Insights from Molecular Dynamics Simulations on Mouse Prion Protein Chimeras ===
 +
<big>Xiaojing Cong, Salvatore Bongarzone, Gabriele Giachin, Giulia Rossetti, Paolo Carloni, Giuseppe Legname</big><ref>doi 10.1080/07391102.2012.712477</ref>
 +
<hr/>
 +
<b>Molecular Tour</b><br>
 +
The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect.
 +
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The &#946;2-&#945;2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the &#946;2-&#945;2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>.
 +
The structural features presented here indicate that stronger interactions between &#945;1 helix and N-terminal of &#945;3 helix are related to the resistance to PrP<sup>C</sup> &#8594; PrP<sup>Sc</sup> conversion, while the &#946;2-&#945;2 loop conformation may play an important role in the dominant-negative effect.
 +
 
 +
</StructureSection>
 +
 
 +
<references/>
 +
__NOEDITSECTION__

Current revision

Drag the structure with the mouse to rotate
  1. Cong X, Bongarzone S, Giachin G, Rossetti G, Carloni P, Legname G. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras. J Biomol Struct Dyn. 2012 Aug 30. PMID:22934595 doi:10.1080/07391102.2012.712477

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools